当前位置:首页 - 行情中心 - 百花医药(600721) - 财务分析 - 利润表

百花医药

(600721)

  

流通市值:30.49亿  总市值:30.49亿
流通股本:3.85亿   总股本:3.85亿

利润表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、营业总收入230,543,932.05157,357,180.8267,182,856.85388,319,392.98
  营业收入230,543,932.05157,357,180.8267,182,856.85388,319,392.98
二、营业总成本197,620,083.89129,665,410.3355,423,758.66310,478,518.94
  营业成本129,117,488.385,243,009.8434,924,216.13211,520,152.12
  税金及附加3,743,039.682,647,216.871,401,599.995,125,162.9
  销售费用8,300,195.145,487,965.71,988,608.4112,028,694.33
  管理费用42,773,849.0627,304,054.1113,221,351.458,457,007.52
  研发费用14,093,299.489,262,222.934,028,059.7924,380,901.15
  财务费用-407,787.77-279,059.12-140,077.06-1,033,399.08
  其中:利息费用--79,787.78-
  其中:利息收入525,742.41382,761.41233,926.831,113,963.44
三、其他经营收益
  加:公允价值变动收益-154,572.04-91,884.75-19,089.87-737,018.3
  加:投资收益1,771,003.381,458,118.73857,955.47-6,559,392.6
  资产处置收益---884.96
  资产减值损失(新)-4,343,502.82-6,586,890.27-3,493,183.16-4,842,406.63
  信用减值损失(新)-11,693,057.5-6,609,926.76-2,234,053.52-22,781,471.24
  其他收益728,566.19723,287.39419,707.461,323,007.63
四、营业利润19,232,285.3716,584,474.837,290,434.5744,244,477.86
  加:营业外收入329,326.84320,532.922,523.33439,255.39
  减:营业外支出266,451.43187,051.5629,540.08521,847.98
五、利润总额19,295,160.7816,717,956.197,263,417.8244,161,885.27
  减:所得税费用2,475,424.091,957,683.73620,693.263,473,948.02
六、净利润16,819,736.6914,760,272.466,642,724.5640,687,937.25
(一)按经营持续性分类
  持续经营净利润16,819,736.6914,760,272.466,642,724.5640,687,937.25
(二)按所有权归属分类
  归属于母公司股东的净利润16,819,736.6914,760,272.466,642,724.5640,687,937.25
  扣除非经常损益后的净利润13,588,511.2212,186,258.295,453,353.0732,785,841.63
七、每股收益
  (一)基本每股收益0.040.040.020.11
  (二)稀释每股收益0.040.040.020.11
八、其他综合收益---40,319.46
  归属于母公司股东的其他综合收益---40,319.46
九、综合收益总额16,819,736.6914,760,272.466,642,724.5640,728,256.71
  归属于母公司股东的综合收益总额16,819,736.6914,760,272.466,642,724.5640,728,256.71
公告日期2026-10-282026-08-252026-04-252026-03-28
审计意见(境内)标准无保留意见
TOP↑